Trial Profile
A Randomised, Single-Blind, Placebo-Controlled, Single-Centre, Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Interaction After Single Ascending Oral Doses of AZD6714 in Healthy Male Volunteers and Male Type II Diabetic Patients.
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs AZD 6714 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- 06 Dec 2010 Planned end date changed from 1 Dec 2009 to 1 Sep 2009 as reported by ClinicalTrials.gov.
- 30 Oct 2009 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 02 Oct 2009 Planned end date changed from 1 Nov 2009 to 1 Dec 2009 as reported by ClinicalTrials.gov.